These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 20805282)

  • 1. Disposition index, glucose effectiveness, and conversion to type 2 diabetes: the Insulin Resistance Atherosclerosis Study (IRAS).
    Lorenzo C; Wagenknecht LE; Rewers MJ; Karter AJ; Bergman RN; Hanley AJ; Haffner SM
    Diabetes Care; 2010 Sep; 33(9):2098-103. PubMed ID: 20805282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin resistance, beta-cell dysfunction, and conversion to type 2 diabetes in a multiethnic population: the Insulin Resistance Atherosclerosis Study.
    Lorenzo C; Wagenknecht LE; D'Agostino RB; Rewers MJ; Karter AJ; Haffner SM
    Diabetes Care; 2010 Jan; 33(1):67-72. PubMed ID: 19808919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and assessment of the disposition index based on the oral glucose tolerance test in subjects with different glycaemic status.
    Santos JL; Yévenes I; Cataldo LR; Morales M; Galgani J; Arancibia C; Vega J; Olmos P; Flores M; Valderas JP; Pollak F
    J Physiol Biochem; 2016 Jun; 72(2):121-31. PubMed ID: 26660757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biomarker models as surrogates for the disposition index in the Insulin Resistance Atherosclerosis Study.
    Watkins SM; Rowe MW; Kolberg JA; Wagenknecht LE; Bergman RN
    Diabet Med; 2012 Nov; 29(11):1399-406. PubMed ID: 22413950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross-sectional and longitudinal changes of glucose effectiveness in relation to glucose tolerance: the insulin resistance atherosclerosis study.
    Lorenzo C; Wagenknecht LE; Karter AJ; Hanley AJ; Rewers MJ; Haffner SM
    Diabetes Care; 2011 Sep; 34(9):1959-64. PubMed ID: 21788626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevations in markers of liver injury and risk of type 2 diabetes: the insulin resistance atherosclerosis study.
    Hanley AJ; Williams K; Festa A; Wagenknecht LE; D'Agostino RB; Kempf J; Zinman B; Haffner SM;
    Diabetes; 2004 Oct; 53(10):2623-32. PubMed ID: 15448093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Performance of a multi-marker diabetes risk score in the Insulin Resistance Atherosclerosis Study (IRAS), a multi-ethnic US cohort.
    Rowe MW; Bergman RN; Wagenknecht LE; Kolberg JA
    Diabetes Metab Res Rev; 2012 Sep; 28(6):519-26. PubMed ID: 22492485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma nonesterified Fatty Acid intolerance and hyperglycemia are associated with intravenous lipid-induced impairment of insulin sensitivity and disposition index.
    Carpentier AC; Bourbonnais A; Frisch F; Giacca A; Lewis GF
    J Clin Endocrinol Metab; 2010 Mar; 95(3):1256-64. PubMed ID: 20097711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surrogate estimates of insulin sensitivity in obese youth along the spectrum of glucose tolerance from normal to prediabetes to diabetes.
    George L; Bacha F; Lee S; Tfayli H; Andreatta E; Arslanian S
    J Clin Endocrinol Metab; 2011 Jul; 96(7):2136-45. PubMed ID: 21508130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin resistance is a poor predictor of type 2 diabetes in individuals with no family history of disease.
    Goldfine AB; Bouche C; Parker RA; Kim C; Kerivan A; Soeldner JS; Martin BC; Warram JH; Kahn CR
    Proc Natl Acad Sci U S A; 2003 Mar; 100(5):2724-9. PubMed ID: 12591951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Longitudinal decline of β-cell function: comparison of a direct method vs a fasting surrogate measure: the Insulin Resistance Atherosclerosis Study.
    Festa A; Haffner SM; Wagenknecht LE; Lorenzo C; Hanley AJ
    J Clin Endocrinol Metab; 2013 Oct; 98(10):4152-9. PubMed ID: 23884776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin sensitivity, insulin secretion and beta-cell function during puberty in overweight Hispanic children with a family history of type 2 diabetes.
    Ball GD; Weigensberg MJ; Cruz ML; Shaibi GQ; Kobaissi HA; Goran MI
    Int J Obes (Lond); 2005 Dec; 29(12):1471-7. PubMed ID: 16077712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin secretion based on the late oral glucose tolerance test period and incident diabetes: the San Antonio Heart Study.
    Lorenzo C; Williams K; Haffner SM
    Diabet Med; 2012 Aug; 29(8):e151-8. PubMed ID: 22435928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased proinsulin levels and decreased acute insulin response independently predict the incidence of type 2 diabetes in the insulin resistance atherosclerosis study.
    Hanley AJ; D'Agostino R; Wagenknecht LE; Saad MF; Savage PJ; Bergman R; Haffner SM;
    Diabetes; 2002 Apr; 51(4):1263-70. PubMed ID: 11916954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased beta-cell function in overweight Latino children with impaired fasting glucose.
    Weigensberg MJ; Ball GD; Shaibi GQ; Cruz ML; Goran MI
    Diabetes Care; 2005 Oct; 28(10):2519-24. PubMed ID: 16186290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin clearance and the incidence of type 2 diabetes in Hispanics and African Americans: the IRAS Family Study.
    Lee CC; Haffner SM; Wagenknecht LE; Lorenzo C; Norris JM; Bergman RN; Stefanovski D; Anderson AM; Rotter JI; Goodarzi MO; Hanley AJ
    Diabetes Care; 2013 Apr; 36(4):901-7. PubMed ID: 23223351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proinsulin-to-C-peptide ratio versus proinsulin-to-insulin ratio in the prediction of incident diabetes: the Insulin Resistance Atherosclerosis Study (IRAS).
    Loopstra-Masters RC; Haffner SM; Lorenzo C; Wagenknecht LE; Hanley AJ
    Diabetologia; 2011 Dec; 54(12):3047-54. PubMed ID: 21959959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A study of the degrees of insulin resistance and first-phase insulin secretion of beta-cells in metabolic syndrome patients with different glucose tolerance].
    Hong J; Gu WQ; Zhang YF; Guo Y; Chen HM; Zhang LZ; Zhao YJ; Ning G
    Zhonghua Yi Xue Za Zhi; 2003 Nov; 83(22):1952-6. PubMed ID: 14703429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low insulin sensitivity (S(i) = 0) in diabetic and nondiabetic subjects in the insulin resistance atherosclerosis study: is it associated with components of the metabolic syndrome and nontraditional risk factors?
    Haffner SM; D'Agostino R; Festa A; Bergman RN; Mykkänen L; Karter A; Saad MF; Wagenknecht LE
    Diabetes Care; 2003 Oct; 26(10):2796-803. PubMed ID: 14514582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship of insulin sensitivity, insulin secretion, and adiposity with insulin clearance in a multiethnic population: the insulin Resistance Atherosclerosis study.
    Lorenzo C; Hanley AJ; Wagenknecht LE; Rewers MJ; Stefanovski D; Goodarzi MO; Haffner SM
    Diabetes Care; 2013 Jan; 36(1):101-3. PubMed ID: 22933441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.